author-photo

Blake Morrison

Sunesis Pharmaceuticals

4

Papers

154

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Prevalence and Incidence of Acute Myeloid Leukemia May be Higher Than Currently Accepted Estimates Among the ≥65 Year-Old Population in the United States

2014 Blood
Show All
- Source
- Cite
- Save
Citations (7)
Safety and efficacy of bortezomib and melphalan combination in patients with relapsed or refractory multiple myeloma: updated results of a phase 1/2 study after longer follow-up.

2008 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (35)
A Phase I/II Study of Arsenic Trioxide/Bortezomib/Ascorbic Acid Combination Therapy for the Treatment of Relapsed or Refractory Multiple Myeloma

2007 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (101)
A Phase I/II Trial Evaluating the Combination of Arsenic Trioxide, Bortezomib and Ascorbic Acid for Patients with Relapsed or Refractory Multiple Myeloma.

2005 Blood
Show All
- Source
- Cite
- Save
Citations (11)